Ambu A S Ord (AMBFF) Q2 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Ambu A/s Class B.

Watch the replay

Replay transcript excerpt

WEBVTT NOTE Transcription provided by Deepgram Request Id: 01a0425b-5e3f-7af1-a5d5-1770bfdca4b4 Created: 2026-08-27T08:34:43.038Z Duration: 3964.6301 Channels: 1 00:00:00.000 -- 00:00:02.639 Hello and good late morning to everyone, 00:00:02.639 -- 00:00:04.400 and welcome to our 00:00:04.880 -- 00:00:07.280 Q2 earnings call for Ambu, 00:00:07.600 -- 00:00:10.080 where we'll go through our business highlights and 00:00:10.080 -- 00:00:13.519 financial results from the second quarter in our 00:00:13.519 -- 00:00:14.160 fiscal year. 00:00:14.955 -- 00:00:16.795 So my name is Britt Milbjorjensen. 00:00:16.795 -- 00:00:18.875 I'm the CEO of Ambu. And with me 00:00:18.875 -- 00:00:20.875 today, I have Henrik Skagbender, 00:00:20.875 -- 00:00:22.715 our Chief Financial Officer. 00:00:24.395 -- 00:00:27.675 So let me start with the business highlights 00:00:27.675 -- 00:00:30.490 from the first six months of 00:00:30.970 -- 00:00:32.329 our financial year, 00:00:32.649 -- 00:00:36.570 starting talking about our key growth driver endoscopy 00:00:36.570 -- 00:00:37.449 solutions, 00:00:37.770 -- 00:00:39.850 where we are leaders in the single use 00:00:39.850 -- 00:00:42.170 market and where we are continuing to drive 00:00:42.170 -- 00:00:44.890 a structural conversion in the market 00:00:45.185 -- 00:00:46.465 from reusable 00:00:46.465 -- 00:00:47.825 to single use. 00:00:48.465 -- 00:00:49.585 We delivered 00:00:49.585 -- 00:00:53.585 in the first half of the year 14.1% 00:00:53.585 -- 00:00:54.305 growth. 00:00:54.625 -- 00:00:55.585 The guidance, 00:00:55.745 -- 00:00:57.745 which we are on plan with for the 00:00:57.745 -- 00:00:59.510 year on Endoscopy 00:00:59.510 -- 00:01:03.270 Solutions is plus 15% revenue growth. 00:01:03.510 -- 00:01:05.670 We also when we set th...